How can we integrate nutritional support in medical oncology?;Comment intégrer la prise en charge nutritionnelle au projet thérapeutique en cancérologie?

Bulletin du Cancer

Volumn 96, Issue 6, 2009, Pages 665-675

  Demoor Goldschmidt, Charlotte ^a   Raynard, Bruno ^b  

^a CRLCC Nantes Antlantiques   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancerology; Diet therapy; Dietary allowance; Enteral nutrition; Feeding; Malignant tumor; Parenteral administration; Weight loss

Indexed keywords

ACETYLCYSTEINE; ALKYLATING AGENT; ALPHA TOCOPHEROL; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARGININE; BETA CAROTENE; BLEOMYCIN; CANNABINOID; CASTASE; CELECOXIB; CISPLATIN; CYPROHEPTADINE; GLUTAMINE; HYDRAZINE SULFATE; IBUPROFEN; IRINOTECAN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MELATONIN; NANDROLONE; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; POLYAMINE DERIVATIVE; PREDNISONE; TAXANE DERIVATIVE; THALIDOMIDE; UNCLASSIFIED DRUG; APPETITE STIMULANT; ESSENTIAL AMINO ACID;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; ARTIFICIAL FEEDING; BLEEDING; BREAST CANCER; CACHEXIA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CORTICOSTEROID THERAPY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETETICS; DRUG ERUPTION; EDEMA; EUPHORIA; GASTROINTESTINAL IRRITATION; HUMAN; MALNUTRITION; MENTAL INSTABILITY; NAUSEA; NEOPLASM; NEUROTOXICITY; NONHUMAN; NUTRITIONAL SUPPORT; ONCOLOGY; OPTIMAL DRUG DOSE; OSTEOPOROSIS; PALLIATIVE THERAPY; PANCREAS CANCER; PARENTERAL NUTRITION; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SOMNOLENCE; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VEIN THROMBOSIS; VERTIGO; VOMITING; XEROSTOMIA; ARTICLE; METHODOLOGY;

AMINO ACIDS, ESSENTIAL; APPETITE STIMULANTS; CACHEXIA; DIETARY SUPPLEMENTS; HUMANS; MALNUTRITION; MEDICAL ONCOLOGY; NEOPLASMS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PROGNOSIS; QUALITY OF LIFE;

EID: 67651012615     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0887     Document Type: Review

References (30)

1. Argiles JM, Lopez-Soriano FJ. New mediators in cancer cachexia. Nestle Nutr Workshop Ser Clin Perform Programme 2000 ; 4 : 147-165
2. McGeer AJ, Detsky AS, O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1990 ; 6 : 233-240 (Pubitemid 20300197)
3. Jin D, Philipps M, Byles JE. Effects of parenteral nutritionsupport and chemotherapy on the phasic composition oftumor cells in gastrointestinal cancer. J Parenter Enteral Nutr 1999 ; 23 : 237-241 (Pubitemid 29309756)
4. Body JJ. The syndrome of anorexia-cachexia. Curr Opin Oncol 1999 ; 11 : 255-260
5. Mac Millan D. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 1999 ; 79 : 495-500. (Pubitemid 29046225)
6. Cerchietti LC, Navigante AH, Peluffo GD, et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symp Manag 2004 ; 27 : 85-95. (Pubitemid 38050252)
7. Kardinal CG. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990 ; 65 : 2657-2662 (Pubitemid 20179539)
8. Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM, et al. Thalidomide in the treatment of fcancer cachexia: a randomised placebo controlled trial. Gut 2005 ; 54 : 540-545 (Pubitemid 40403032)
9. Persson C, Glimelius B, Ronnelid J, Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 2005 ; 21 : 170-178 (Pubitemid 40255726)
10. Strasser F, Luftner D, Possinger K, et al. Comparaison of orally administred cannabis extract ans delta-9-tetrahydrocannabitol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-bind, placebocontrolled clinical trial from the cannabis-in-cachexia-study-group. J Clin Oncol 2006 ; 24 : 3394-3400 (Pubitemid 46638895)
11. Desport JC, Blanc-Vincent MP, Gory-Delabaere G, et al. Standards, Options and Recommendations for the use of appetite stimulants in oncology. Bull Cancer 2000 ; 87 : 315-328
12. Déchelotte R. « Pharmacological nutrition and immune nutrition in cancer patients ». In : Cynober L, Furst R, Lawin R (eds). Pharmacological nutrition-Immune nutrition. Munich : Zuckschwerdt Verlag, 1995, p. 122-134
13. Van Zaanen HCT, van der Lelie H, Timmer JG, Ftirst E, Sauerwein H. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 1994 ; 74 : 2879-2884 (Pubitemid 24340559)
14. Bozzetti F, Biganzoli L, Gavazzi C, Cappuzzo, Carnaghi C, Buzzoni R, et al. Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study. Nutrition 1997 ; 13 : 7-8. (Pubitemid 27347185)
15. Skubitz KM, Anderson PM. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med 1996 ; 127 : 223-228 (Pubitemid 2626797)
16. Richards EW, Log CL, Pinkston JA. The role of oral glutamine supplementation in the prevention of radiation-induced enterocolltis in prostate cancer patients. FASEB 1992 ; 6 : A1680 (abstract).
17. Brittenden J, Heys SD, Miller I, Sarkar TK, Hutcheon AW, Needham G, et al. Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. Br J Cancer 1994 ; 69 : 918-921 (Pubitemid 24140675)
18. Gogos CA, Ginopoulos E, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos E. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolonge survival for severely ill patients with generalized malignancy. A randomized control trial. Cancer 1998 ; 15 (82) : 395-402. (Pubitemid 28060258)
19. Conklin KA. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern Med Rev 2002 ; 7 : 4-21. (Pubitemid 34203977)
20. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 2007 ; 1 : CD004597. (Pubitemid 351820443)
21. Raynard B. Les compléments nutritionnels oraux en cancérologie (en dehors de la période péri opératoire). Nutr Clin Métabol 2005 ; 19 : 102-105 (Pubitemid 40824623)
22. Colomer R, Moreno-Nogueira JM, García-Luna PP, García-Peris P, García-de-Lorenzo A, Zarazaga A, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007 ; 97 : 823-831 (Pubitemid 46554396)
23. Raynard B, Antoun S. Prise en charge nutritionnelle et médicamenteuse de la cachexie cancéreuse. Nutr Clin Métabol 2006 ; 20 : 133-136
24. Desport JC, Blanc-Vincent MP, Gory-Delabaere G, et al. Standards, Options and Recommendations for the use of appetite stimulants in oncology. Bull Cancer 2000 ; 87 : 315-328
25. Meuric J, Garabige V, Blanc-Vincent MP, Lallemand Y, Bachmann P. Bonnes pratiques pour la prise en charge diététique des patients atteints de cancer des voies aérodigestives supérieures. Standards, Options, Recommandations. Bull Cancer 1999 ; 86 : 843-854
26. Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006 ; 119 : 2221-2224 (Pubitemid 44423684)
27. Tozer RG, Tai P, Falconer W, et al. Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal 2008 ; 10 : 395-402.
28. Moulinoux JP. Conférence « Cancer et nutrition : les polyamines, une nouvelle approche thérapeutique », Nantes, avril 2008.
29. Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, et al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 2008 ; 24 : 305-313
30. Tran M, Raynard B, Bataillard A, Duguet A, Garabige V, Lallemand Y, et al. Standards, Options and Recommendations 2005 for a good practice in enteral nutrition in oncology (summary report.). Bull Cancer 2006 ; 93 : 715-722